Form 4: Honeywell CEO Exercises Options, Sells Shares
Insider Transaction Report
Honeywell International Inc.'s President and CEO of Industrial Automation, Lucian Boldea, exercised stock options and subsequently sold a significant number of common shares.
Summary
- Lucian Boldea, President and CEO of Industrial Automation at Honeywell International Inc., engaged in multiple transactions on August 27, 2025.
- Exercised employee stock options for a total of 36,181 shares of common stock, with exercise prices ranging from $171.73 to $199.60 per share.
- Sold a total of 42,149 shares of common stock at weighted average prices ranging from $221.4404 to $221.6036 per share.
- The sales were executed at prices ranging from $221.2250 to $221.9300.
- Following these transactions, direct beneficial ownership stands at 10,334 shares, with an additional 259.1954 shares held indirectly in a 401(k) plan.
- The transactions were made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 6
Explanation: The filing reports routine insider transactions (option exercises and sales) by a key executive. While the sales reduce the executive's direct ownership, they were conducted under a 10b5-1 plan, which mitigates concerns about opportunistic selling. The executive realized a profit, which is a positive for the individual, but the overall impact on company sentiment is neutral to slightly negative due to the reduction in direct holdings.
Positives
- The executive realized a profit from exercising stock options and selling shares at a higher market price, indicating personal financial gain.
- The transactions were conducted under a Rule 10b5-1(c) plan, suggesting pre-planned and orderly disposition of shares, which can reduce concerns about opportunistic insider trading.
Negatives
- The significant sale of shares by a high-ranking executive could be interpreted by some investors as a reduction in direct exposure to the company's stock, although it is often for diversification or liquidity purposes.
- The net reduction in direct beneficial ownership by the executive after these transactions.
Future Outlook
The filing does not contain explicit forward-looking statements or guidance regarding the company's future performance. However, it details future vesting schedules for employee stock options, indicating continued long-term incentive alignment for the executive.
Management Comments
- The Reporting Person undertakes to provide to Honeywell International Inc, any security holder of Honeywell International Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Industry Context
This Form 4 filing reflects routine executive compensation and liquidity management activities common across publicly traded companies. The exercise of stock options and subsequent sale of shares is a standard practice for executives to realize value from their equity awards, often as part of pre-arranged trading plans. It does not provide specific insights into broader industry trends for the industrial automation sector or Honeywell's competitive position.
Comparison to Industry Standards
- This filing is a standard disclosure of insider transactions. There are no specific company or project results to compare against global benchmarks.
- The transactions themselves, being option exercises and sales, are typical for executives in large, established companies like Honeywell International Inc.
- The use of a Rule 10b5-1 plan aligns with best practices for insider trading compliance, similar to executives at companies such as General Electric or Siemens, who also frequently utilize such plans for their equity compensation.
Related Party Transactions
- Lucian Boldea, an executive of Honeywell International Inc., exercised stock options and sold common shares of the company, which constitutes a related-party transaction.
Stakeholder Impact
- Shareholders: May view the executive's share sales with mixed sentiment; some may see it as a routine liquidity event, while others might interpret it as a signal of reduced confidence, despite the 10b5-1 plan.
- Management: The executive realized significant personal financial gain from exercising options and selling shares.
Next Steps
- Vesting of 8,796 employee stock options on October 3, 2025.
- Vesting of 5,951 employee stock options on February 10, 2026.
- Vesting of 6,683 employee stock options on February 16, 2026.
- Vesting of 8,797 employee stock options on October 3, 2026.
- Vesting of 5,951 employee stock options on February 10, 2027.
- Vesting of 6,683 employee stock options on February 16, 2027.
- Vesting of 6,684 employee stock options on February 16, 2028.
Key Dates
| Date | Description |
|---|---|
| 2025-05-30 | Lucian Boldea signed the Confirming Statement designating agents for SEC filings. |
| 2025-08-27 | Date of earliest transaction for stock option exercises and common stock sales. |
| 2025-10-03 | Vesting date for 8,796 employee stock options from the first grant. |
| 2026-02-10 | Vesting date for 5,951 employee stock options from the second grant. |
| 2026-02-16 | Vesting date for 6,683 employee stock options from the third grant. |
| 2026-10-03 | Vesting date for 8,797 employee stock options from the first grant. |
| 2027-02-10 | Vesting date for 5,951 employee stock options from the second grant. |
| 2027-02-16 | Vesting date for 6,683 employee stock options from the third grant. |
| 2028-02-16 | Vesting date for 6,684 employee stock options from the third grant. |
| 2032-10-02 | Expiration date for employee stock options with an exercise price of $171.73. |
| 2033-02-09 | Expiration date for employee stock options with an exercise price of $199.60. |
| 2034-02-15 | Expiration date for employee stock options with an exercise price of $197.68. |
Recommendation
holdThis Form 4 filing details routine insider transactions by a key executive, involving the exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 plan. Such transactions are common for executive compensation and personal financial management and do not typically signal a change in the company's fundamental outlook or operational performance. While the executive reduced direct share ownership, the pre-planned nature mitigates concerns about opportunistic selling. Therefore, the filing itself does not provide new information warranting a change in investment thesis, leading to a 'hold' recommendation based solely on this disclosure.
Keywords
Honeywell International Inc., HON, Insider Trading, Form 4, Stock Options, Share Sale, Executive Compensation, Lucian Boldea, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.